Taipei Exchange - Delayed Quote TWD

Intech Biopharm Corporation (6461.TWO)

18.00
-0.20
(-1.10%)
At close: June 4 at 1:30:32 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
32,668
39,779
25,847
23,647
38,899
Cost of Revenue
197,698
197,404
189,842
170,909
158,269
Gross Profit
-165,030
-157,625
-163,995
-147,262
-119,370
Operating Expense
202,748
198,502
156,473
170,818
174,612
Operating Income
-367,778
-356,127
-320,468
-318,080
-293,982
Net Non Operating Interest Income Expense
-29,741
-28,424
-29,169
-21,111
-18,692
Pretax Income
-381,658
-368,207
-337,987
-327,877
-301,756
Net Income Common Stockholders
-381,658
-368,207
-337,987
-327,877
-301,756
Diluted NI Available to Com Stockholders
-381,658
-368,207
-337,987
-327,877
-301,756
Basic EPS
-2.77
-2.68
-2.81
-2.82
-2.89
Diluted EPS
-2.77
-2.68
-2.81
-2.82
-2.89
Basic Average Shares
137,754.59
137,288
120,462
116,133
104,402.42
Diluted Average Shares
137,754.59
137,288
120,462
116,133
104,402.42
Total Expenses
400,446
395,906
346,315
341,727
332,881
Net Income from Continuing & Discontinued Operation
-381,658
-368,207
-337,987
-327,877
-301,756
Normalized Income
-381,658
-368,207
-337,987
-327,877
-301,756
Interest Income
4,524
5,734
4,422
1,929
848
Interest Expense
34,265
34,158
33,591
23,040
19,540
Net Interest Income
-29,741
-28,424
-29,169
-21,111
-18,692
EBIT
-347,393
-334,049
-304,396
-304,837
-282,216
EBITDA
-258,785
-246,696
-219,585
-219,482
-196,920
Reconciled Cost of Revenue
197,698
197,404
189,842
170,909
158,269
Reconciled Depreciation
88,608
87,353
84,811
85,355
85,296
Net Income from Continuing Operation Net Minority Interest
-381,658
-368,207
-337,987
-327,877
-301,756
Normalized EBITDA
-258,785
-246,696
-219,585
-219,482
-196,920
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/15/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4130.TWO Genovate Biotechnology Co., Ltd.
21.40
+0.47%
 
6492.TWO Senhwa Biosciences, Inc.
33.70
+0.15%
 
4167.TWO Savior Lifetec Corporation
21.40
+0.94%
 
3118.TWO Level Biotechnology Inc.
34.00
+0.29%
 
3205.TWO Sagittarius Life Science Corp
44.60
-2.19%
 
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
88.10
+0.11%
 
3176.TWO Medigen Biotechnology Corp.
31.35
+2.79%
 
4726.TWO Mycenax Biotech Inc.
37.60
0.00%
 
3164.TW GenMont Biotech Incorporation
20.30
+0.50%
 
6733.TWO BioGend Therapeutics Co., Ltd.
31.00
0.00%